No indications for platelet activation in acute clinical myocardial or renal ischemia/reperfusion injury

Kirsten A. Kortekaas, Dorottya K. de Vries, Mark Roest, Marlies E. J. Reinders, Eric P. van der Veer, Robert J. M. Klautz, Philip G. de Groot, Alexander F. Schaapherder, Jan H. Lindeman*

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review


    The pathophysiology of ischemia/reperfusion (I/R) injury is complex and poorly understood. Animal studies imply platelet activation as an initiator of the inflammatory response upon reperfusion. However, it remains unclear whether and how these results translate to clinical I/R. This study evaluates putative platelet activation in the context of two forms of clinical I/R (heart valve surgery with aortic-cross clamping, n = 39 and kidney transplantation, n = 34). The technique of sequential selective arteriovenous (AV) measurements over the reperfused organs was applied to exclude the influence of systemic changes occurring during surgery while simultaneously maximizing sensitivity. Platelet activation and degranulation was evaluated by assessing the expression levels of established markers, i.e. RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted), ss-thromboglobulin (ss-TG), platelet-derived growth factor (PDGF)-BB and CXCL8 (known as interleukin-8), and by employing an in-vitro assay that specifically tests for platelet excitability. Moreover, a histological analysis was performed by means of CD41 staining. Results show stable RANTES, ss-TG, PDGF-BB and CXCL8 AV-concentrations within the first half hour over the reperfused organs, suggesting that myocardial and renal I/R are not associated with platelet activation. Results from the platelet excitability assay were in line with these findings and indicated reduced and stable platelet excitability following renal and myocardial reperfusion, respectively. Histological analysis yield evidence of platelet marginalization in the reperfused organs. In conclusion, results from this study do not support a role for platelet activation in early phases of clinical I/R injury.
    Original languageEnglish
    Pages (from-to)816-826
    Number of pages11
    JournalAmerican Journal of Translational Research
    Issue number3
    Publication statusPublished - 30 Mar 2018


    • Ischemia
    • reperfusion
    • inflammation
    • platelets
    • DAMAGE

    Cite this